FI101883B1 - Menetelmä terapeuttisesti käyttökelpoisten 19,11 -sillan käsittävien steroidien valmistamiseksi - Google Patents

Menetelmä terapeuttisesti käyttökelpoisten 19,11 -sillan käsittävien steroidien valmistamiseksi

Info

Publication number
FI101883B1
FI101883B1 FI894364A FI894364A FI101883B1 FI 101883 B1 FI101883 B1 FI 101883B1 FI 894364 A FI894364 A FI 894364A FI 894364 A FI894364 A FI 894364A FI 101883 B1 FI101883 B1 FI 101883B1
Authority
FI
Finland
Prior art keywords
radical
hydrogen atom
alkyl radical
image
bond
Prior art date
Application number
FI894364A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI894364A0 (fi
FI101883B (fi
Inventor
Eckhard Ottow
Rudolf Wiechert
Guenter Neef
Sybille Beier
Walter Elger
David Andrew Henderson
Original Assignee
Schering Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Ag filed Critical Schering Ag
Publication of FI894364A0 publication Critical patent/FI894364A0/fi
Priority to FI951834A priority Critical patent/FI103795B/fi
Application granted granted Critical
Publication of FI101883B publication Critical patent/FI101883B/fi
Publication of FI101883B1 publication Critical patent/FI101883B1/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0057—Nitrogen and oxygen
    • C07J71/0063—Nitrogen and oxygen at position 2(3)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/38—Drugs for disorders of the endocrine system of the suprarenal hormones
    • A61P5/44—Glucocorticosteroids; Drugs increasing or potentiating the activity of glucocorticosteroids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J21/00—Normal steroids containing carbon, hydrogen, halogen or oxygen having an oxygen-containing hetero ring spiro-condensed with the cyclopenta(a)hydrophenanthrene skeleton
    • C07J21/005—Ketals
    • C07J21/006—Ketals at position 3
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J31/00—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring
    • C07J31/006—Normal steroids containing one or more sulfur atoms not belonging to a hetero ring not covered by C07J31/003
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J41/00—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring
    • C07J41/0033—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005
    • C07J41/0038—Normal steroids containing one or more nitrogen atoms not belonging to a hetero ring not covered by C07J41/0005 with an androstane skeleton, including 18- or 19-substituted derivatives, 18-nor derivatives and also derivatives where position 17-beta is substituted by a carbon atom not directly bonded to a further carbon atom and not being part of an amide group
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J53/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton has been modified by condensation with a carbocyclic rings or by formation of an additional ring by means of a direct link between two ring carbon atoms, including carboxyclic rings fused to the cyclopenta(a)hydrophenanthrene skeleton are included in this class
    • C07J53/002—Carbocyclic rings fused
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0005—Oxygen-containing hetero ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07J—STEROIDS
    • C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
    • C07J71/0036—Nitrogen-containing hetero ring
    • C07J71/0042—Nitrogen only
    • C07J71/0047—Nitrogen only at position 2(3)

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Endocrinology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Diabetes (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • External Artificial Organs (AREA)
  • Separation By Low-Temperature Treatments (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
FI894364A 1987-03-18 1989-09-15 Menetelmä terapeuttisesti käyttökelpoisten 19,11 -sillan käsittävien steroidien valmistamiseksi FI101883B1 (fi)

Priority Applications (1)

Application Number Priority Date Filing Date Title
FI951834A FI103795B (fi) 1987-03-18 1995-04-18 19,11beta-sillan käsittäviä steroideja

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
DE3708942 1987-03-18
DE19873708942 DE3708942A1 (de) 1987-03-18 1987-03-18 19,11ss-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE8800150 1988-03-11
PCT/DE1988/000150 WO1988007051A1 (fr) 1987-03-18 1988-03-11 STEROIDES 19,11beta POLYNUCLEAIRES, LEUR PRODUCTION ET PREPARATIONS PHARMACEUTIQUES LES CONTENANT

Publications (3)

Publication Number Publication Date
FI894364A0 FI894364A0 (fi) 1989-09-15
FI101883B FI101883B (fi) 1998-09-15
FI101883B1 true FI101883B1 (fi) 1998-09-15

Family

ID=6323462

Family Applications (1)

Application Number Title Priority Date Filing Date
FI894364A FI101883B1 (fi) 1987-03-18 1989-09-15 Menetelmä terapeuttisesti käyttökelpoisten 19,11 -sillan käsittävien steroidien valmistamiseksi

Country Status (19)

Country Link
US (1) US5095129A (cs)
EP (1) EP0283428B1 (cs)
JP (1) JP2588267B2 (cs)
CN (3) CN1033033C (cs)
AT (1) ATE69055T1 (cs)
AU (1) AU628015B2 (cs)
CA (1) CA1326015C (cs)
DD (1) DD273262A5 (cs)
DE (2) DE3708942A1 (cs)
ES (1) ES2040373T3 (cs)
FI (1) FI101883B1 (cs)
GR (1) GR3003362T3 (cs)
HU (2) HU206368B (cs)
IE (1) IE62480B1 (cs)
IL (1) IL85773A (cs)
NZ (1) NZ223924A (cs)
PT (1) PT87007B (cs)
WO (1) WO1988007051A1 (cs)
ZA (1) ZA881962B (cs)

Families Citing this family (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5446178A (en) * 1987-03-18 1995-08-29 Schering Aktiengesellschaft Process for preparing 19,11β-bridged steroids
DE3832303A1 (de) * 1988-09-20 1990-04-12 Schering Ag 11ss-phenyl-14ssh-steroide
DE3917274A1 (de) * 1989-05-24 1990-11-29 Schering Ag 9(alpha)-hydroxy-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
DE3921059A1 (de) * 1989-06-23 1991-01-10 Schering Ag 11(beta)-aryl-4-estrene, verfahren zu ihrer herstellung sowie deren verwendung als arzneimittel
DD289541A5 (de) * 1989-08-04 1991-05-02 ��@�K@�������������@�K@��������������@��������k�� Verfahren zur herstellung von 11beta-aryl-16 alpha, 17 alph-cyclohexanoestra-4,9-dienen
DE4038128A1 (de) * 1990-11-27 1992-06-04 Schering Ag 8-en-19, 11(beta)-ueberbrueckte steroide, deren herstellung und diese enthaltende pharmazeutische praeparate
US5439913A (en) * 1992-05-12 1995-08-08 Schering Aktiengesellschaft Contraception method using competitive progesterone antagonists and novel compounds useful therein
DE4235220A1 (de) * 1992-10-13 1994-06-16 Schering Ag Gestagen wirksame 19,11ß-überbrückte 4-Estrene
DE4413184A1 (de) * 1994-04-12 1995-10-19 Schering Ag 10,11-C¶3¶-überbrückte Steroide
DE4413185A1 (de) * 1994-04-12 1995-10-19 Schering Ag 11beta,19-überbrückte 13alpha-Alkylsteroide
DE4417880A1 (de) * 1994-05-18 1995-11-23 Schering Ag 19,11beta-Überbrückte 18-Nor-Steroide, Verfahren zu ihrer Herstellung, diese Steroide enthaltende Arzneimittel sowie deren Verwendung zur Herstellung von Arzneimitteln
US5639598A (en) * 1994-05-19 1997-06-17 The Trustees Of The University Of Pennsylvania Method and kit for identification of antiviral agents capable of abrogating HIV Vpr-Rip-1 binding interactions
US5780220A (en) * 1994-05-19 1998-07-14 Trustees Of The University Of Pennsylvania Methods and compositions for inhibiting HIV replication
DE4424222C1 (de) * 1994-07-09 1995-09-14 Metallgesellschaft Ag Gelöstes Methyllithium enthaltendes Synthesemittel sowie Verfahren zu deren Herstellung
DE4434488A1 (de) 1994-09-14 1996-03-21 Schering Ag Steroidester und -amide, Verfahren zu ihrer Herstellung und ihre pharmazeutische Verwendung
US5521166A (en) * 1994-12-19 1996-05-28 Ortho Pharmaceitical Corporation Antiprogestin cyclophasic hormonal regimen
ZA9510926B (en) 1994-12-23 1996-07-03 Schering Ag Compounds with progesterone-antagonistic and antiestrogenic action to be used together for female contraception
IL118974A (en) * 1995-08-17 2001-09-13 Akzo Nobel Nv History 11 - (Transformed Phenyl) - Astra - 4, 9 - Diane, their preparation and pharmaceutical preparations containing them
DE19652408C2 (de) * 1996-12-06 2002-04-18 Schering Ag Steroidester, Verfahren zu ihrer Herstellung und ihre Verwendung zur Herstellung von Arzneimitteln
US6090798A (en) * 1997-12-19 2000-07-18 Alcon Laboratories, Inc. Treatment of GLC1A glaucoma with glucocorticoid antagonists
GB0000313D0 (en) 2000-01-10 2000-03-01 Astrazeneca Uk Ltd Formulation
HUE051484T2 (hu) 2006-10-24 2021-03-01 Allergan Pharmaceuticals Int Ltd Készítmények és eljárások az endometriális proliferációk elnyomására
TWI539953B (zh) 2008-04-28 2016-07-01 瑞波若斯治療學公司 用於治療乳癌之組成物和方法
WO2011119194A1 (en) 2010-03-22 2011-09-29 Repros Therapeutics Inc. Compositions and methods for non-toxic delivery of antiprogestins
WO2011150209A1 (en) 2010-05-26 2011-12-01 Corcept Therapeutics, Inc. Treatment of muscular dystrophy
CN103555806B (zh) * 2013-11-16 2015-05-13 江南大学 一种高效利用亚麻刺盘孢霉合成7α-羟基-雄甾烯酮的方法
WO2016140867A1 (en) 2015-03-02 2016-09-09 Corcept Therapeutics, Inc. Use of glucocorticoid receptor antagonist and somatostatin analogues to treat acth-secreting tumors
JP6754533B2 (ja) 2015-03-30 2020-09-16 コーセプト セラピューティクス， インコーポレイテッド 副腎機能不全を処置するための糖質コルチコイドと組み合わせた糖質コルチコイドレセプターアンタゴニストの使用
KR20180052120A (ko) 2015-08-13 2018-05-17 코어셉트 쎄라퓨틱스, 잉크. Acth-의존성 쿠싱 증후군을 감별 진단하는 방법
CA3011728A1 (en) 2016-01-19 2017-07-27 Corcept Therapeutics, Inc. Differential diagnosis of ectopic cushing's syndrome
MX2019011543A (es) 2017-03-31 2019-12-16 Corcept Therapeutics Inc Moduladores del receptor de glucocorticoides para el tratamiento de cancer cervical.
CA3065555A1 (en) 2017-06-20 2018-12-27 Corcept Therapeutics, Inc. Methods of treating neuroepithelial tumors using selective glucocorticoid receptor modulators
AU2021400069A1 (en) 2020-12-18 2023-07-06 Instil Bio (Uk) Limited Processing of tumor infiltrating lymphocytes

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA8231B (en) * 1981-01-09 1982-11-24 Roussel Uclaf New 11 -substituted steroid derivatives, their preparation, their use as medicaments, the compositions containing them and the new intermediates thus obtained
FR2522328B1 (fr) * 1982-03-01 1986-02-14 Roussel Uclaf Nouveaux produits derives de la structure 3-ceto 4,9 19-nor steroides, leur procede de preparation et leur application comme medicaments
FR2576025B1 (fr) * 1985-01-14 1987-01-23 Roussel Uclaf Nouveaux steroides substitues en position 10, leur procede et les intermediaires de preparation, leur application comme medicaments, les compositions pharmaceutiques les contenant

Also Published As

Publication number Publication date
PT87007A (pt) 1988-04-01
NZ223924A (en) 1991-12-23
CA1326015C (en) 1994-01-11
HU206368B (en) 1992-10-28
FI894364A0 (fi) 1989-09-15
ES2040373T3 (es) 1993-10-16
IL85773A (en) 1994-01-01
PT87007B (pt) 1992-06-30
GR3003362T3 (en) 1993-02-17
IL85773A0 (en) 1988-09-30
DE3708942A1 (de) 1988-09-29
AU1420988A (en) 1988-10-10
CN1141926A (zh) 1997-02-05
CN1135488A (zh) 1996-11-13
CN88102162A (zh) 1988-11-23
ATE69055T1 (de) 1991-11-15
FI101883B (fi) 1998-09-15
HU210532A9 (en) 1995-04-28
DE3865863D1 (cs) 1991-12-05
US5095129A (en) 1992-03-10
CN1033033C (zh) 1996-10-16
WO1988007051A1 (fr) 1988-09-22
JP2588267B2 (ja) 1997-03-05
IE62480B1 (en) 1995-02-08
DD273262A5 (de) 1989-11-08
CN1057770C (zh) 2000-10-25
HU911518D0 (en) 1991-11-28
EP0283428B1 (de) 1991-10-30
AU628015B2 (en) 1992-09-10
ZA881962B (en) 1988-09-08
JPH02503194A (ja) 1990-10-04
IE880793L (en) 1988-09-18
EP0283428A1 (de) 1988-09-21
CN1080267C (zh) 2002-03-06

Similar Documents

Publication Publication Date Title
FI101883B1 (fi) Menetelmä terapeuttisesti käyttökelpoisten 19,11 -sillan käsittävien steroidien valmistamiseksi
IE792028L (en) Pyrroloazetidinones
TW249804B (cs)
DK96783A (da) Fremgangsmaade til fremstilling af 4''-epierythromycin a eller derivater deraf
EP0008249A3 (en) Fluorene and fluoranthene derivatives, process for their preparation, their therapeutic application and intermediates
HUT50142A (en) Process for producing allyl-mercapto-acetyl-sidnonimine derivatives and pharmaceutical compositions containing them
ES8205224A1 (es) Un procedimiento para la preparacion de acidos 1-carbadetiapen-2-em-3-carboxilios 6-1-y 2-sustituidos.
ATE54148T1 (de) Neue cephalosporine und verfahren zu ihrer herstellung.
DK479688D0 (da) Substituerede 3-aminosydnoniminer og farmakologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
DK522889A (da) Substituerede 3-aminosydnoniminer og farmakologisk acceptable syreadditionssalte deraf, deres fremstilling og anvendelse
FI951834L (fi) 19,11 -sillan käsittäviä steroideja
GR3021336T3 (en) New process for the preparation of 20-oxo, 17-alpha, 21-dihydroxy derivatives of pregnane and new intermediates thereof.
FR2338041A1 (fr) Nouveaux acides furobenzoxazolyl-acethydroxamiques, leur procede de preparation et leur application en therapeutique
EP0200145A3 (en) Process for the preparation of optically active azole derivatives
IE780933L (en) Pregnene derivatives
DE3361150D1 (en) Steroid esters of n-(2-halogen-ethyl)-n-nitroso-carbamoyl amino acids and their peptides, and process for their preparation
IE812732L (en) 3-amino steroid compounds
HK1005881A1 (en) Pregna-1,4-diene-3,20-dione-16-17-acetal-21 esters
GB2282810A (en) Process for the preparation of clavulanic acid
FI921238A7 (fi) Välituotteina käytettävät N'-alkoksi- tai N'-aralkyylioksi-N6-syano-griseoliinihapon johdannaiset
FI875626A0 (fi) Foerfarande foer framstaellning av dibenzo/be/ixepinaettiksyraderivat.
ATE130309T1 (de) 14alpha,16alpha-ethano- und 14alpha,16alpha- ethenoestratriene.
GB1251821A (cs)

Legal Events

Date Code Title Description
MM Patent lapsed

Owner name: SCHERING AKTIENGESELLSCHAFT

MA Patent expired